{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:39:33Z","timestamp":1792096773191,"version":"4.4.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,30]],"date-time":"2019-12-30T00:00:00Z","timestamp":1577664000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,12,30]],"date-time":"2019-12-30T00:00:00Z","timestamp":1577664000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Osteoarthritis (OA) is one of the world\u2019s most common degenerative diseases, but there is no disease-modifying treatment available. Previous studies have shown that prostaglandin E2 (PGE<jats:sub>2<\/jats:sub>) and PGE2 receptor 4 (EP<jats:sub>4<\/jats:sub>) are involved in OA pathogenesis; however, their roles are not fully understood. Here, we examined the efficacy of oral administration of KAG-308, an EP<jats:sub>4<\/jats:sub>-selective agonist, in surgically induced mouse knee OA. Cartilage degeneration and synovitis were significantly inhibited by the KAG-308 treatment. Chondrocyte hypertrophy and expression of tumor necrosis factor alpha (TNF) and matrix metalloproteinase 13 (Mmp13) in the synovium were suppressed in the KAG-308-treated mice. In cultured chondrocytes, hypertrophic differentiation was inhibited by KAG-308 and intranuclear translocation of histone deacetylase 4 (Hdac4) was enhanced. In cultured synoviocytes, lipopolysaccharide (LPS)-induced expression of TNF and Mmp13 was also suppressed by KAG-308. KAG-308 was detected in the synovium and cartilage of orally treated mice. TNF secretion from the synovia of KAG-308-treated mice was significantly lower than control mice. Thus, we conclude that oral administration of KAG-308 suppresses OA development through suppression of chondrocyte hypertrophy and synovitis. KAG-308 may be a potent candidate for OA drug development.<\/jats:p>","DOI":"10.1038\/s41598-019-56861-6","type":"journal-article","created":{"date-parts":[[2019,12,30]],"date-time":"2019-12-30T11:02:44Z","timestamp":1577703764000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Oral administration of EP4-selective agonist KAG-308 suppresses mouse knee osteoarthritis development through reduction of chondrocyte hypertrophy and TNF secretion"],"prefix":"10.1038","volume":"9","author":[{"given":"Yasutaka","family":"Murahashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiko","family":"Yano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3125-4818","authenticated-orcid":false,"given":"Ryota","family":"Chijimatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Nakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Maenohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Amakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihide","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Yamanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kousuke","family":"Iba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakae","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taku","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,30]]},"reference":[{"key":"56861_CR1","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1016\/S0140-6736(19)30417-9","volume":"393","author":"DJ Hunter","year":"2019","unstructured":"Hunter, D. J. & Bierma-Zeinstra, S. Osteoarthritis. Lancet 393, 1745\u20131759 (2019).","journal-title":"Lancet"},{"key":"56861_CR2","doi-asserted-by":"publisher","first-page":"990","DOI":"10.3390\/cells8090990","volume":"8","author":"G Schulze-Tanzil","year":"2019","unstructured":"Schulze-Tanzil, G. Intraarticular Ligament Degeneration Is Interrelated with Cartilage and Bone Destruction in Osteoarthritis. Cells 8, 990 (2019).","journal-title":"Cells"},{"key":"56861_CR3","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.semarthrit.2013.11.012","volume":"43","author":"AE Nelson","year":"2014","unstructured":"Nelson, A. E., Allen, K. D., Golightly, Y. M., Goode, A. P. & Jordan, J. M. A systematic review of recommendations and guidelines for the management of osteoarthritis: The chronic osteoarthritis management initiative of the U.S. bone and joint initiative. Semin. Arthritis Rheum. 43, 701\u2013712 (2014).","journal-title":"Semin. Arthritis Rheum."},{"key":"56861_CR4","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.joca.2014.01.003","volume":"22","author":"TE McAlindon","year":"2014","unstructured":"McAlindon, T. E. et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthr. Cartil. 22, 363\u2013388 (2014).","journal-title":"Osteoarthr. Cartil."},{"key":"56861_CR5","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/nature03369","volume":"434","author":"SS Glasson","year":"2005","unstructured":"Glasson, S. S. et al. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature 434, 644\u2013648 (2005).","journal-title":"Nature"},{"key":"56861_CR6","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.joca.2005.03.004","volume":"13","author":"S Kamekura","year":"2005","unstructured":"Kamekura, S. et al. Osteoarthritis development in novel experimental mouse models induced by knee joint instability. Osteoarthr. Cartil. 13, 632\u2013641 (2005).","journal-title":"Osteoarthr. Cartil."},{"key":"56861_CR7","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.joca.2016.09.024","volume":"25","author":"EN Blaney Davidson","year":"2017","unstructured":"Blaney Davidson, E. N., van Caam, A. P. & van der Kraan, P. M. Osteoarthritis year in review 2016: biology. Osteoarthr. Cartil. 25, 175\u2013180 (2017).","journal-title":"Osteoarthr. Cartil."},{"key":"56861_CR8","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1002\/art.22041","volume":"54","author":"S Kamekura","year":"2006","unstructured":"Kamekura, S. et al. Contribution of runt-related transcription factor 2 to the pathogenesis of osteoarthritis in mice after induction of knee joint instability. Arthritis Rheum. 54, 2462\u20132470 (2006).","journal-title":"Arthritis Rheum."},{"key":"56861_CR9","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nm.2146","volume":"16","author":"T Saito","year":"2010","unstructured":"Saito, T. et al. Transcriptional regulation of endochondral ossification by HIF-2alpha during skeletal growth and osteoarthritis development. Nat. Med. 16, 678\u2013686 (2010).","journal-title":"Nat. Med."},{"key":"56861_CR10","doi-asserted-by":"publisher","first-page":"28620","DOI":"10.1074\/jbc.M113.452169","volume":"288","author":"H Kobayashi","year":"2013","unstructured":"Kobayashi, H. et al. Transcriptional induction of ADAMTS5 protein by nuclear factor-\u03baB (NF-\u03baB) family member RelA\/p65 in chondrocytes during osteoarthritis development. J. Biol. Chem. 288, 28620\u201328629 (2013).","journal-title":"J. Biol. Chem."},{"key":"56861_CR11","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/322547a0","volume":"322","author":"J Saklatvala","year":"1986","unstructured":"Saklatvala, J. Tumour necrosis factor alpha stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature 322, 547\u2013549 (1986).","journal-title":"Nature"},{"key":"56861_CR12","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.intimp.2015.07.003","volume":"28","author":"S Cheleschi","year":"2015","unstructured":"Cheleschi, S. et al. Chondroprotective effect of three different classes of anti-inflammatory agents on human osteoarthritic chondrocytes exposed to IL-1\u03b2. Int. Immunopharmacol. 28, 794\u2013801 (2015).","journal-title":"Int. Immunopharmacol."},{"key":"56861_CR13","first-page":"374","volume":"18","author":"J Chen","year":"2017","unstructured":"Chen, J. et al. Efficacy and Safety of Tanezumab on Osteoarthritis Knee and Hip Pains: A Meta-Analysis of Randomized Controlled Trials. Pain. Med. 18, 374\u2013385 (2017).","journal-title":"Pain. Med."},{"key":"56861_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10959","volume":"7","author":"Y Yahara","year":"2016","unstructured":"Yahara, Y. et al. Pterosin B prevents chondrocyte hypertrophy and osteoarthritis in mice by inhibiting Sik3. Nat. Commun. 7, 10959 (2016).","journal-title":"Nat. Commun."},{"key":"56861_CR15","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/ar3437","volume":"13","author":"MC Zweers","year":"2011","unstructured":"Zweers, M. C. et al. Celecoxib: considerations regarding its potential disease-modifying properties in osteoarthritis. Arthritis Res. Ther. 13, 239 (2011).","journal-title":"Arthritis Res. Ther."},{"key":"56861_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-34830-9","volume":"8","author":"Y Murahashi","year":"2018","unstructured":"Murahashi, Y. et al. Intra-articular administration of I\u03baB\u03b1 kinase inhibitor suppresses mouse knee osteoarthritis via downregulation of the NF-\u03baB\/HIF-2\u03b1 axis. Sci. Rep. 8, 16475 (2018).","journal-title":"Sci. Rep."},{"key":"56861_CR17","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1007\/s10753-017-0630-5","volume":"40","author":"T Jia","year":"2017","unstructured":"Jia, T., Qiao, J., Guan, D. & Chen, T. Anti-Inflammatory Effects of Licochalcone A on IL-1\u03b2-Stimulated Human Osteoarthritis Chondrocytes. Inflammation 40, 1894\u20131902 (2017).","journal-title":"Inflammation"},{"key":"56861_CR18","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.intimp.2018.08.025","volume":"64","author":"S Cheleschi","year":"2018","unstructured":"Cheleschi, S. et al. In vitro comprehensive analysis of VA692 a new chemical entity for the treatment of osteoarthritis. Int. Immunopharmacol. 64, 86\u2013100 (2018).","journal-title":"Int. Immunopharmacol."},{"key":"56861_CR19","doi-asserted-by":"publisher","first-page":"5082","DOI":"10.4049\/jimmunol.181.7.5082","volume":"181","author":"M Attur","year":"2008","unstructured":"Attur, M. et al. Prostaglandin E2 exerts catabolic effects in osteoarthritis cartilage: evidence for signaling via the EP4 receptor. J. Immunol. 181, 5082\u20135088 (2008).","journal-title":"J. Immunol."},{"key":"56861_CR20","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/art.24258","volume":"60","author":"X Li","year":"2009","unstructured":"Li, X. et al. PGE2 and its cognate EP receptors control human adult articular cartilage homeostasis and are linked to the pathophysiology of osteoarthritis. Arthritis Rheum. 60, 513\u2013523 (2009).","journal-title":"Arthritis Rheum."},{"key":"56861_CR21","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.joca.2017.01.018","volume":"25","author":"HS J\u00f3nasd\u00f3ttir","year":"2017","unstructured":"J\u00f3nasd\u00f3ttir, H. S. et al. Targeted lipidomics reveals activation of resolution pathways in knee osteoarthritis in humans. Osteoarthr. Cartil. 25, 1150\u20131160 (2017).","journal-title":"Osteoarthr. Cartil."},{"key":"56861_CR22","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1002\/art.10356","volume":"46","author":"MM Hardy","year":"2002","unstructured":"Hardy, M. M. et al. Cyclooxygenase 2-dependent prostaglandin E2 modulates cartilage proteoglycan degradation in human osteoarthritis explants. Arthritis Rheum. 46, 1789\u20131803 (2002).","journal-title":"Arthritis Rheum."},{"key":"56861_CR23","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/0952-3278(90)90002-3","volume":"39","author":"O Sahap Atik","year":"1990","unstructured":"Sahap Atik, O. Leukotriene B4 and prostaglandin E2-like activity in synovial fluid in osteoarthritis. Prostaglandins Leukot. Essent. Fat. Acids 39, 253\u2013254 (1990).","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"56861_CR24","doi-asserted-by":"publisher","first-page":"R75","DOI":"10.1186\/ar2273","volume":"9","author":"EV Tchetina","year":"2007","unstructured":"Tchetina, E. V., Di Battista, J. A., Zukor, D. J., Antoniou, J. & Poole, A. R. Prostaglandin PGE2 at very low concentrations suppresses collagen cleavage in cultured human osteoarthritic articular cartilage: this involves a decrease in expression of proinflammatory genes, collagenases and COL10A1, a gene linked to chondrocyte hypertrophy. Arthritis Res. Ther. 9, R75 (2007).","journal-title":"Arthritis Res. Ther."},{"key":"56861_CR25","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1152\/physrev.1999.79.4.1193","volume":"79","author":"S Narumiya","year":"1999","unstructured":"Narumiya, S., Sugimoto, Y. & Ushikubi, F. Prostanoid receptors: structures, properties, and functions. Physiol. Rev. 79, 1193\u20131226 (1999).","journal-title":"Physiol. Rev."},{"key":"56861_CR26","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1136\/ard.2006.065946","volume":"67","author":"SC Mastbergen","year":"2008","unstructured":"Mastbergen, S. C., Bijlsma, J. W. & Lafeber, F. P. Synthesis and release of human cartilage matrix proteoglycans are differently regulated by nitric oxide and prostaglandin-E2. Ann. Rheum. Dis. 67, 52\u201358 (2008).","journal-title":"Ann. Rheum. Dis."},{"key":"56861_CR27","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1124\/pr.110.003517","volume":"63","author":"DF Woodward","year":"2011","unstructured":"Woodward, D. F., Jones, R. L. & Narumiya, S. International Union of Basic and Clinical Pharmacology. LXXXIII: classification of prostanoid receptors, updating 15 years of progress. Pharmacol. Rev. 63, 471\u2013538 (2011).","journal-title":"Pharmacol. Rev."},{"key":"56861_CR28","first-page":"213","volume":"46","author":"JW Regan","year":"1994","unstructured":"Regan, J. W. et al. Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype. Mol. Pharmacol. 46, 213\u2013220 (1994).","journal-title":"Mol. Pharmacol."},{"key":"56861_CR29","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1124\/pr.112.007195","volume":"65","author":"U Yokoyama","year":"2013","unstructured":"Yokoyama, U., Iwatsubo, K., Umemura, M., Fujita, T. & Ishikawa, Y. The prostanoid EP4 receptor and its signaling pathway. Pharmacol. Rev. 65, 1010\u20131052 (2013).","journal-title":"Pharmacol. Rev."},{"key":"56861_CR30","doi-asserted-by":"crossref","first-page":"6675","DOI":"10.1073\/pnas.1705420114","volume":"114","author":"ATV Ho","year":"2017","unstructured":"Ho, A. T. V. et al. Prostaglandin E2 is essential for efficacious skeletal muscle stem-cell function, augmenting regeneration and strength. Proc. Natl Acad. Sci. USA 114, 6675\u20136684 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"56861_CR31","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/S1063-4584(03)00118-3","volume":"11","author":"M Miyamoto","year":"2003","unstructured":"Miyamoto, M. et al. Simultaneous stimulation of EP2 and EP4 is essential to the effect of prostaglandin E2 in chondrocyte differentiation. Osteoarthr. Cartil. 11, 644\u2013652 (2003).","journal-title":"Osteoarthr. Cartil."},{"key":"56861_CR32","first-page":"E376","volume":"276","author":"M Weinreb","year":"1999","unstructured":"Weinreb, M., Grosskopf, A. & Shir, N. The anabolic effect of PGE2 in rat bone marrow cultures is mediated via the EP4 receptor subtype. Am. J. Physiol. 276, E376\u2013383 (1999).","journal-title":"Am. J. Physiol."},{"key":"56861_CR33","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/jcb.22421","volume":"109","author":"K Nishitani","year":"2010","unstructured":"Nishitani, K. et al. PGE2 Inhibits MMP Expression by Suppressing MKK4\u2013JNK MAP Kinase\u2013c-JUN Pathway via EP4 in Human Articular Chondrocytes. J. Cell Biochem. 109, 425\u2013433 (2010).","journal-title":"J. Cell Biochem."},{"key":"56861_CR34","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1002\/jcb.21099","volume":"100","author":"K Fushimi","year":"2007","unstructured":"Fushimi, K., Nakashima, S., You, F., Takigawa, M. & Shimizu, K. Prostaglandin E2 downregulates TNF-alpha-induced production of matrix metalloproteinase-1 in HCS-2\/8 chondrocytes by inhibiting Raf-1\/MEK\/ERK cascade through EP4 prostanoid receptor activation. J. Cell Biochem. 100, 783\u2013793 (2007).","journal-title":"J. Cell Biochem."},{"key":"56861_CR35","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1002\/ibd.21080","volume":"16","author":"H Nakase","year":"2010","unstructured":"Nakase, H. et al. Effect of EP4 agonist (ONO-4819CD) for patients with mild to moderate ulcerative colitis refractory to 5-aminosalicylates: a randomized phase II, placebo-controlled trial. Inflamm. Bowel Dis. 16, 731\u2013733 (2010).","journal-title":"Inflamm. Bowel Dis."},{"key":"56861_CR36","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ejphar.2015.02.021","volume":"754","author":"Y Watanabe","year":"2015","unstructured":"Watanabe, Y. et al. KAG-308, a newly-identified EP4-selective agonist shows efficacy for treating ulcerative colitis and can bring about lower risk of colorectal carcinogenesis by oral administration. Eur. J. Pharmacol. 754, 179\u2013189 (2015).","journal-title":"Eur. J. Pharmacol."},{"key":"56861_CR37","doi-asserted-by":"publisher","first-page":"5751","DOI":"10.1128\/MCB.00415-09","volume":"29","author":"E Kozhemyakina","year":"2009","unstructured":"Kozhemyakina, E., Cohen, T., Yao, T. P. & Lassar, A. B. Parathyroid hormone-related peptide represses chondrocyte hypertrophy through a protein phosphatase 2A\/histone deacetylase 4\/MEF2 pathway. Mol. Cell Biol. 29, 5751\u20135762 (2009).","journal-title":"Mol. Cell Biol."},{"key":"56861_CR38","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1242\/dev.105536","volume":"142","author":"E Kozhemyakina","year":"2015","unstructured":"Kozhemyakina, E., Lassar, A. B. & Zelzer, E. A pathway to bone: signaling molecules and transcription factors involved in chondrocyte development and maturation. Development 142, 817\u2013831 (2015).","journal-title":"Development"},{"key":"56861_CR39","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1016\/j.bbamcr.2016.04.018","volume":"1863","author":"C Chen","year":"2016","unstructured":"Chen, C. et al. Compression regulates gene expression of chondrocytes through HDAC4 nuclear relocation via PP2A-dependent HDAC4 dephosphorylation. Biochim. Biophys. Acta 1863, 1633\u20131642 (2016).","journal-title":"Biochim. Biophys. Acta"},{"key":"56861_CR40","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1242\/dev.072652","volume":"139","author":"S Sasagawa","year":"2012","unstructured":"Sasagawa, S. et al. SIK3 is essential for chondrocyte hypertrophy during skeletal development in mice. Development 139, 1153\u20131163 (2012).","journal-title":"Development"},{"key":"56861_CR41","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.immuni.2008.12.021","volume":"30","author":"K Koga","year":"2009","unstructured":"Koga, K. et al. Cyclic adenosine monophosphate suppresses the transcription of proinflammatory cytokines via the phosphorylated c-Fos protein. Immunity 30, 372\u2013383 (2009).","journal-title":"Immunity"},{"key":"56861_CR42","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/nrrheum.2013.109","volume":"9","author":"F Barry","year":"2013","unstructured":"Barry, F. & Murphy, M. Mesenchymal stem cells in joint disease and repair. Nat. Rev. Rheumatol. 9, 584\u2013594 (2013).","journal-title":"Nat. Rev. Rheumatol."},{"key":"56861_CR43","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/jcp.21200","volume":"213","author":"AI Caplan","year":"2007","unstructured":"Caplan, A. I. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J. Cell Physiol. 213, 341\u2013347 (2007).","journal-title":"J. Cell Physiol."},{"key":"56861_CR44","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1002\/art.10118","volume":"46","author":"JM Murphy","year":"2002","unstructured":"Murphy, J. M. et al. Reduced chondrogenic and adipogenic activity of mesenchymal stem cells from patients with advanced osteoarthritis. Arthritis Rheum. 46, 704\u2013713 (2002).","journal-title":"Arthritis Rheum."},{"key":"56861_CR45","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.prostaglandins.2009.03.001","volume":"89","author":"F Kojima","year":"2009","unstructured":"Kojima, F. et al. Prostaglandin E2 activates Rap1 via EP2\/EP4 receptors and cAMP-signaling in rheumatoid synovial fibroblasts: involvement of Epac1 and PKA. Prostaglandins Other Lipid Mediat. 89, 26\u201333 (2009).","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"56861_CR46","doi-asserted-by":"publisher","first-page":"4664","DOI":"10.1096\/fj.13-234542","volume":"27","author":"P Wang","year":"2013","unstructured":"Wang, P. et al. Fluid shear stress-induced osteoarthritis: roles of cyclooxygenase-2 and its metabolic products in inducing the expression of proinflammatory cytokines and matrix metalloproteinases. FASEB J. 27, 4664\u20134677 (2013).","journal-title":"FASEB J."},{"key":"56861_CR47","doi-asserted-by":"publisher","first-page":"44147","DOI":"10.1074\/jbc.M204810200","volume":"277","author":"K Takayama","year":"2002","unstructured":"Takayama, K. et al. Prostaglandin E2 suppresses chemokine production in human macrophages through the EP4 receptor. J. Biol. Chem. 277, 44147\u201344154 (2002).","journal-title":"J. Biol. Chem."},{"key":"56861_CR48","first-page":"446","volume":"84","author":"WW Zhong","year":"1995","unstructured":"Zhong, W. W., Burke, P. A., Drotar, M. E., Chavali, S. R. & Forse, R. A. Effects of prostaglandin E2, cholera toxin and 8-bromo-cyclic AMP on lipopolysaccharide-induced gene expression of cytokines in human macrophages. Immunology 84, 446\u2013452 (1995).","journal-title":"Immunology"},{"key":"56861_CR49","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13075-017-1229-9","volume":"19","author":"A Mathiessen","year":"2017","unstructured":"Mathiessen, A. & Conaghan, P. G. Synovitis in osteoarthritis: current understanding with therapeutic implications. Arthritis Res. Ther. 19, 18 (2017).","journal-title":"Arthritis Res. Ther."},{"key":"56861_CR50","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.joca.2005.01.005","volume":"13","author":"X Ayral","year":"2005","unstructured":"Ayral, X., Pickering, E. H., Woodworth, T. G., Mackillop, N. & Dougados, M. Synovitis: a potential predictive factor of structural progression of medial tibiofemoral knee osteoarthritis\u2013results of a 1 year longitudinal arthroscopic study in 422 patients. Osteoarthr. Cartil. 13, 361\u2013367 (2005).","journal-title":"Osteoarthr. Cartil."},{"key":"56861_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13336","volume":"7","author":"H Kobayashi","year":"2016","unstructured":"Kobayashi, H. et al. Biphasic regulation of chondrocytes by Rela through induction of anti-apoptotic and catabolic target genes. Nat. Commun. 7, 13336 (2016).","journal-title":"Nat. Commun."},{"key":"56861_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09491-5","volume":"10","author":"SH Chang","year":"2019","unstructured":"Chang, S. H. et al. Excessive mechanical loading promotes osteoarthritis through the gremlin-1-NF-\u03baB pathway. Nat. Commun. 10, 1442 (2019).","journal-title":"Nat. Commun."},{"key":"56861_CR53","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.devcel.2007.02.004","volume":"12","author":"MA Arnold","year":"2007","unstructured":"Arnold, M. A. et al. MEF2C transcription factor controls chondrocyte hypertrophy and bone development. Dev. Cell 12, 377\u2013389 (2007).","journal-title":"Dev. Cell"},{"key":"56861_CR54","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/nprot.2008.95","volume":"3","author":"M Gosset","year":"2008","unstructured":"Gosset, M., Berenbaum, F., Thirion, S. & Jacques, C. Primary culture and phenotyping of murine chondrocytes. Nat. Protoc. 3, 1253\u20131260 (2008).","journal-title":"Nat. Protoc."},{"key":"56861_CR55","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/j.1365-2559.2006.02508.x","volume":"49","author":"V Krenn","year":"2006","unstructured":"Krenn, V. et al. Synovitis score: discrimination between chronic low-grade and high-grade synovitis. Histopathology 49, 358\u2013364 (2006).","journal-title":"Histopathology"},{"key":"56861_CR56","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1016\/j.joca.2010.05.025","volume":"18","author":"SS Glasson","year":"2010","unstructured":"Glasson, S. S., Chambers, M. G., Van Den Berg, W. B. & Little, C. B. The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the mouse. Osteoarthr. Cartil. 18, S17\u201323 (2010).","journal-title":"Osteoarthr. Cartil."},{"key":"56861_CR57","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1002\/cbin.10689","volume":"40","author":"QF Gao","year":"2016","unstructured":"Gao, Q. F., Zhang, X. H., Yuan, F. L., Zhao, M. D. & Li, X. Recombinant human endostatin inhibits TNF-alpha-induced receptor activator of NF-\u03baB ligand expression in fibroblast-like synoviocytes in mice with adjuvant arthritis. Cell Biol. Int. 40, 1340\u20131348 (2016).","journal-title":"Cell Biol. Int."},{"key":"56861_CR58","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.freeradbiomed.2018.03.042","volume":"125","author":"T McGarry","year":"2018","unstructured":"McGarry, T., Biniecka, M., Veale, D. J. & Fearon, U. Hypoxia, oxidative stress and inflammation. Free. Radic. Biol. Med. 125, 15\u201324 (2018).","journal-title":"Free. Radic. Biol. Med."},{"key":"56861_CR59","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1161\/HYPERTENSIONAHA.114.03654","volume":"64","author":"F Wang","year":"2014","unstructured":"Wang, F. et al. Prostaglandin E-prostanoid4 receptor mediates angiotensin II-induced (pro)renin receptor expression in the rat renal medulla. Hypertension 64, 369\u2013377 (2014).","journal-title":"Hypertension"},{"key":"56861_CR60","doi-asserted-by":"publisher","first-page":"e79463","DOI":"10.1371\/journal.pone.0079463","volume":"8","author":"M Kondo","year":"2013","unstructured":"Kondo, M. et al. IL-17 inhibits chondrogenic differentiation of human mesenchymal stem cells. PLoS One 8, e79463 (2013).","journal-title":"PLoS One"},{"key":"56861_CR61","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1136\/annrheumdis-2016-210478","volume":"76","author":"F Eymard","year":"2017","unstructured":"Eymard, F. et al. Knee and hip intra-articular adipose tissues (IAATs) compared with autologous subcutaneous adipose tissue: a specific phenotype for a central player in osteoarthritis. Ann. Rheum. Dis. 76, 1142\u20131148 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"56861_CR62","doi-asserted-by":"publisher","first-page":"9552","DOI":"10.1073\/pnas.85.24.9552","volume":"85","author":"Y Kato","year":"1988","unstructured":"Kato, Y., Iwamoto, M., Koike, T., Suzuki, F. & Takano, Y. Terminal differentiation and calcification in rabbit chondrocyte cultures grown in centrifuge tubes: regulation by transforming growth factor beta and serum factors. Proc. Natl Acad. Sci. USA 85, 9552\u20139556 (1988).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"56861_CR63","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen, T. D. & Livak, K. J. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 3, 1101\u20131108 (2008).","journal-title":"Nat. Protoc."},{"key":"56861_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.399","volume":"4","author":"S Kumar","year":"2013","unstructured":"Kumar, S. et al. Autophagy triggered by magnolol derivative negatively regulates angiogenesis. Cell Death Dis. 4, e889 (2013).","journal-title":"Cell Death Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-56861-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-56861-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-56861-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T09:39:42Z","timestamp":1722245982000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-56861-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,30]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["56861"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-56861-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,30]]},"assertion":[{"value":"27 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20329"}}